References
- Posner JB. Management of chronic pain. In: Beeson PB, McDermott W, Wyngaarden JB, eds. Cecil textbook of medicine. 15th ed. Philadelphia: WB. Saunders, 1979:722–8
- WHO Expert Committee on Drug Dependence. Sixteenth report. WHO Tech Rep Ser 407, 1969
- Manaky PA. Addiction, in: Synder SH, Matthysse S, eds. Opiate receptor mechanisms. Boston: MIT Press. 1975:17–20
- Synder SH. The opiate receptorand morphine-like peptides in the brain. Am J Psychol 1978;135:645–52
- Simon EJ. Opiate receptor binding with 3H-etorphine. In: Synder, Matthysse, eds,3 pp. 43–50
- Korf J, Bunney BS, Aghajanian GK. Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol 1974;25:165–9
- Ketchum JS, Jarvik ME. Pharmacotherapy for the opioid addict: agonists or antagonists? Ration Drug Ther 1979;13:1–5
- Sperber SB, Meyer DR. The capacity of Clonidine to antagonize withdrawal in morphine-dependent rats. Pharmacologist 1976;18:236–8
- Gold MS, Pottash AC, Sweeney DR, et al. Opiate withdrawal using Clonidine: a safe, effective, and rapid nonopiate treatment. JAMA 1980;243:343–6
- Gold MS, Redmond DE. Jr. Pharmacological activation and inhibition of noradrenergic activity alter specific behaviors in nonhuman primates. (Abstr) Neuroscience 1977:3:250
- Gold MS, Redmond DE. Jr, Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 1978;2:599–602
- Gold MS, Byck R, Sweeney DR, et al. Endorphin-locus coeruleus connection mediates opiate action and withdrawal. Biomedicine 1979;30:1–4
- DiGregorio GJ, Bukovlnsky MA. Clonidine for narcotic withdrawal. Family Physician 1981;24:203–4
- Gold MS, Pottash AL, Extein I, et al. Clonidine and opiate withdrawal. Lancet 1980;2:1078–9
- Paaizow G. Development of tolerance to the analgesic effect of Clonidine in rats: cross-tolerance to morphine. Naunyn Schmiedebergs Arch Pharmacol 1978;304:1–4
- Hoder EL, Leckman JF, Ehrenkranz R, et al. Clonidine in neonatal narcotic-abstinence syndrome. N Engl J Med 1981;305:1284